Cabot's Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure.
Cabot NYSE: CBT reported third-quarter fiscal 2026 adjusted earnings per share of $1.67, up 4% sequentially, as strength in its Performance Chemicals segment helped offset lower earnings in Reinforcement Materials.
Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT's disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures.
Cabot (CBT) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.9 per share a year ago.
Cabot (CBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how Cabot (CBT) and CF Industries (CF) have performed compared to their sector so far this year.
CBT's battery materials momentum, portfolio expansion and cost actions support growth despite weak tire demand and near-term cash-flow pressure.
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
CBT beat fiscal Q2 earnings estimates as battery materials demand and favorable product mix helped offset weaker pricing and softer revenues.
Cabot Corporation (CBT) Q2 2026 Earnings Call Transcript
FDS and peers lift dividends as volatile markets and inflation fears push investors toward steady income plays backed by solid fundamentals.
Cabot (CBT) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.9 per share a year ago.